Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant SNCA (Exidavnemab Biosimilar) anticorps (Biotin)

L’anticorps anti-SNCA (Exidavnemab Biosimilar) Monoclonal Humanized est utilisé pour la détection de SNCA (Exidavnemab Biosimilar) dans des échantillons de Humain.
N° du produit ABIN7830173
465,23 €
Plus frais de livraison 40,00 € et TVA
50 μg
Destination: France
Envoi sous 38 à 50 jours ouvrables

Aperçu rapide pour Recombinant SNCA (Exidavnemab Biosimilar) anticorps (Biotin) (ABIN7830173)

Antigène

SNCA (Exidavnemab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Humain

Hôte

  • 1
Humanized

Clonalité

  • 1
Monoclonal

Conjugué

  • 1
Cet anticorp SNCA (Exidavnemab Biosimilar) est conjugé à/à la Biotin

Application

Veuillez nous consulter SVP

Classe de qualité

Research Grade
  • Fonction

    Biotinylated Anti-SNCA(exidavnemab biosimilar) mAb

    Isotype

    IgG4
  • Commentaires

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Please see Certificate of Analysis for specific instructions of reconstitution.

    Buffer

    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

    Date de péremption

    12 months
  • Antigène

    SNCA (Exidavnemab Biosimilar)

    Autre désignation

    Exidavnemab Biosimilar

    Sujet

    Synonyms Target:PD1,NACP,PARK1,PARK4
    Synonyms Antibody:PR-1808164,PR1808164,ABBV-0805,ABBV0805,ABBV805,ABBV-805,BAN-0805,BAN0805,BAN805,BAN-805,PD-0805,PD0805,PD-805,PD805

    UniProt

    P37840
Vous êtes ici:
Chat with us!